{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antibody", "Molecular dynamics simulation", "SARS-CoV-2", "TMPRSS2", "hACE2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36964244", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "05", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "24"}], "Language": ["eng"], "ELocationID": ["109", "10.1007/s00894-023-05509-4"], "Journal": {"ISSN": "0948-5023", "JournalIssue": {"Volume": "29", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "24"}}, "Title": "Journal of molecular modeling", "ISOAbbreviation": "J Mol Model"}, "ArticleTitle": "Molecular recognition of SARS-CoV-2 spike protein with three essential partners: exploring possible immune escape mechanisms of viral mutants.", "Pagination": {"StartPage": "109", "MedlinePgn": "109"}, "Abstract": {"AbstractText": ["The COVID-19 epidemic is raging around the world, with the emergence of viral mutant\u00a0strains such as Delta and Omicron, posing severe challenges to people's health and\u00a0quality of life. A full understanding life cycle of the virus in host cells helps to reveal\u00a0inactivation mechanism of antibody and provide inspiration for the development of a\u00a0new-generation vaccines.", "In this work, molecular recognitions and conformational changes of SARS-CoV-2 spike\u00a0protein mutants (i.e., Delta, Mu, and Omicron) and three essential partners (i.e.,\u00a0membrane receptor hACE2, protease TMPRSS2, and antibody C121) both were\u00a0compared and analyzed using molecular simulations.", "Water basin and binding free energy calculations both show that the three mutants\u00a0possess higher affinity for hACE2 than WT, exhibiting stronger virus transmission. The\u00a0descending order of cleavage ability by TMPRSS2 is Mu, Delta, Omicron, and WT,\u00a0which is related to the new S1/S2 cutting site induced by transposition effect. The\u00a0inefficient utilization of TMPRSS2 by Omicron is consistent with its primary entry into cells via the endosomal pathway. In addition, RBD-directed antibody C121 showed obvious resistance to Omicron, which may have originated from high fluctuation of\u00a0approaching angles, high flexibility of I472-F490 loop, and reduced binding ability.", "According to the overall characteristics of the three mutants, high infectivity, high\u00a0immune escape, and low virulence may be the future evolutionary selection of SARS-CoV-2. In a word, this work not only proposes the possible resistance mechanism of\u00a0SARS-CoV-2 mutants, but also provides theoretical guidance for the subsequent drug\u00a0design against COVID-19 based on S protein structure."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Breast Disease Center, West China Hospital, Sichuan University, Cancer CenterChengdu, 610000, China."}], "LastName": "Cheng", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Breast Disease Center, West China Hospital, Sichuan University, Cancer CenterChengdu, 610000, China."}], "LastName": "Zheng", "ForeName": "Dan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Marxism, Chengdu Vocational & Technical College of Industry, Chengdu, China."}], "LastName": "Zhang", "ForeName": "Derong", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Breast Disease Center, West China Hospital, Sichuan University, Cancer CenterChengdu, 610000, China."}], "LastName": "Guo", "ForeName": "Du", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China."}], "LastName": "Wang", "ForeName": "Yueteng", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China."}], "LastName": "Liu", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China."}], "LastName": "Liang", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China."}], "LastName": "Hu", "ForeName": "Jianping", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Breast Disease Center, West China Hospital, Sichuan University, Cancer CenterChengdu, 610000, China. luotingwch@163.com."}], "LastName": "Luo", "ForeName": "Ting", "Initials": "T"}], "GrantList": [{"GrantID": "31870655", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "2019YFH0054", "Agency": "Sichuan\u00a0Science\u00a0and\u00a0Technology\u00a0Program", "Country": ""}, {"GrantID": "10Y202104", "Agency": "Project of Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "J Mol Model", "NlmUniqueID": "9806569", "ISSNLinking": "0948-5023"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": ["genetics"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["genetics"], "DescriptorName": "Spike Glycoprotein, Coronavirus"}, {"QualifierName": [], "DescriptorName": "Mutation"}], "CoiStatement": "The authors declare no competing interests. The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237\u2013261. doi: 10.1146/annurev-virology-110615-042301.", "ArticleIdList": ["10.1146/annurev-virology-110615-042301", "PMC5457962", "27578435"]}, {"Citation": "Zhong NS, Zheng BJ, Li YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet. 2003;362(9393):0\u20131358. doi: 10.1016/s0140-6736(03)14630-2.", "ArticleIdList": ["10.1016/s0140-6736(03)14630-2", "PMC7112415", "14585636"]}, {"Citation": "De Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523\u2013534. doi: 10.1038/nrmicro.2016.81.", "ArticleIdList": ["10.1038/nrmicro.2016.81", "PMC7097822", "27344959"]}, {"Citation": "Li F. Receptor recognition and cross-species infections of SARS coronavirus. Antiviral Res. 2013;100(1):246\u2013254. doi: 10.1016/j.antiviral.2013.08.014.", "ArticleIdList": ["10.1016/j.antiviral.2013.08.014", "PMC3840050", "23994189"]}, {"Citation": "Zaki AM, Van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814. doi: 10.1056/NEJMoa1211721.", "ArticleIdList": ["10.1056/NEJMoa1211721", "23075143"]}, {"Citation": "MD Shin, Shukla S, Chung YH, et al (2020) COVID-19 vaccine development and a potential nanomaterial path forward. Nat. Nanotechnol. 15(8). 10.1038/s41565-020-0737-y.", "ArticleIdList": ["32669664"]}, {"Citation": "Rabaan AA, Al-Ahmed SH, Haque S, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview. Infez Med. 2020;28(2):174\u2013184.", "ArticleIdList": ["32275259"]}, {"Citation": "Ortega JT, Serrano ML, Pujol FH, Rangel HR. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis. EXCLI J. 2020;19:410\u2013417. doi: 10.17179/excli2020-1167.", "ArticleIdList": ["10.17179/excli2020-1167", "PMC7081066", "32210742"]}, {"Citation": "Sahin A, Erdogan A, MutluAgaoglu P, et al. novel coronavirus (COVID-19) outbreak: a review of the current literature. Eurasian J Med Oncol. 2020;4(1):1\u20137. doi: 10.14744/ejmo.2020.12220.", "ArticleIdList": ["10.14744/ejmo.2020.12220"]}, {"Citation": "Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Sci. 2020;367(6485):eabb2762. doi: 10.1126/science.abb2762.", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res. 2019;105:93\u2013116. doi: 10.1016/bs.aivir.2019.08.002.", "ArticleIdList": ["10.1016/bs.aivir.2019.08.002", "PMC7112261", "31522710"]}, {"Citation": "Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. NAT MICROBIOL. 2020;5:562\u2013569. doi: 10.1038/s41564-020-0688-y.", "ArticleIdList": ["10.1038/s41564-020-0688-y", "PMC7095430", "32094589"]}, {"Citation": "Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Cold Spring Harbor Lab. 2020;367:1260\u20131263. doi: 10.1126/science.abb2507.", "ArticleIdList": ["10.1126/science.abb2507", "PMC7164637", "32075877"]}, {"Citation": "Walls AC, Park YJ, Tortorici MA, et al. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281\u2013292. doi: 10.1016/j.cell.2020.02.058.", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u2013280.e8. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94(7):e00127\u2013e220. doi: 10.1128/JVI.00127-20.", "ArticleIdList": ["10.1128/JVI.00127-20", "PMC7081895", "31996437"]}, {"Citation": "Sztain TE, Ahn SH, Bogetti AT, et al. A glycan gate controls opening of the SARS-CoV-2 spike protein. Nat Chem. 2021;13:963\u2013968. doi: 10.1038/s41557-021-00758-3.", "ArticleIdList": ["10.1038/s41557-021-00758-3", "PMC8488004", "34413500"]}, {"Citation": "Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u2013273. doi: 10.1038/s41586-020-2951-z.", "ArticleIdList": ["10.1038/s41586-020-2951-z", "PMC7095418", "32015507"]}, {"Citation": "Yao H, Song Y, Chen Y, et al. Molecular architecture of the SARS-CoV-2 virus. Cell. 2020;183(3):730\u2013738. doi: 10.1016/j.cell.2020.09.018.", "ArticleIdList": ["10.1016/j.cell.2020.09.018", "PMC7474903", "32979942"]}, {"Citation": "Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A. 2009;106(14):5871\u20135876. doi: 10.1073/pnas.0809524106.", "ArticleIdList": ["10.1073/pnas.0809524106", "PMC2660061", "19321428"]}, {"Citation": "Vankadari N. Structure of furin protease binding to SARS-CoV-2 spike glycoprotein and implications for potential targets and virulence. J Phys Chem Lett. 2020;11(16):6655\u20136663. doi: 10.1021/acs.jpclett.0c01698.", "ArticleIdList": ["10.1021/acs.jpclett.0c01698", "32787225"]}, {"Citation": "Cai Y, Zhang J, Xiao T, et al. Distinct conformational states of SARS-CoV-2 spike protein. Sci. 2020;369(6511):eabd4251. doi: 10.1126/science.abd4251.", "ArticleIdList": ["10.1126/science.abd4251", "PMC7464562", "32694201"]}, {"Citation": "Rey FA, Lok SM. Common features of enveloped viruses and implications for immunogen design for next-generation vaccines. Cell. 2018;172(6):1319\u20131334. doi: 10.1016/j.cell.2018.02.054.", "ArticleIdList": ["10.1016/j.cell.2018.02.054", "PMC7112304", "29522750"]}, {"Citation": "Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2021;21:73\u201382. doi: 10.1038/s41577-020-00480-0.", "ArticleIdList": ["10.1038/s41577-020-00480-0", "PMC7747004", "33340022"]}, {"Citation": "Bestle D, Heindl MR, Limburg H, et al. TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets. BioRxiv. 2020;3:e202000786. doi: 10.1101/2020.04.15.042085.", "ArticleIdList": ["10.1101/2020.04.15.042085", "PMC7383062", "32703818"]}, {"Citation": "COVID-19 vaccine tracker: vaccine landscape. https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/_w_ec54614e/#tab-1609-6 (accessed June 25, 2021)."}, {"Citation": "COVID-19 vaccine tracker: clinical trials database. https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/_w_ec54614e/#tab-1609-2 (accessed June 25, 2021)."}, {"Citation": "Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med. 2021;385(7):585\u2013594. doi: 10.1056/NEJMc2113090.", "ArticleIdList": ["10.1056/NEJMc2113090", "PMC8314739", "34289274"]}, {"Citation": "Fontanet A, Autran B, Lina B, et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet. 2021;397(10278):952\u2013954. doi: 10.1016/S0140-6736(21)00370-6.", "ArticleIdList": ["10.1016/S0140-6736(21)00370-6", "PMC7906631", "33581803"]}, {"Citation": "Our world in data: coronavirus (COVID-19) vaccinations: https://ourworldindata.org/covid-vaccinations (accessed June 25, 2021)."}, {"Citation": "Juno JA, Wheatley AK. Boosting immunity to COVID-19 vaccines. Nat Med. 2021;27(11):1874\u20131875. doi: 10.1038/s41591-021-01560-x.", "ArticleIdList": ["10.1038/s41591-021-01560-x", "34764485"]}, {"Citation": "Dekervel M, Henry N, Torreggiani M, et al. Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis. Oxford University Press (OUP) 2021;14(11):2349\u20132355. doi: 10.1093/CKJ/SFAB152.", "ArticleIdList": ["10.1093/CKJ/SFAB152", "PMC8573007", "34754430"]}, {"Citation": "Jones BE, Brown-Augsburger PL, Corbett KS, et al. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med. 2021;13(593):eab1906. doi: 10.1126/scitranslmed.abf1906.", "ArticleIdList": ["10.1126/scitranslmed.abf1906", "PMC8284311", "33820835"]}, {"Citation": "Anon, 2020. An EUA for casirivimab and imdevimab for COVID-19. Med. Lett. Drugs Ther.62 (1614), 201\u2013202. https://publons.com/wos-op/search/?search=An+EUA+for+Casirivimab+and+Imdevimab+for+COVID-19 (accessed July 13, 2021).", "ArticleIdList": ["33451174"]}, {"Citation": "Anon, 2021. An EUA for sotrovimab for treatment of COVID-19. Med. Lett. Drugs Ther.63 (1627), 97\u201398. https://publons.com/wos-op/search/?search=An+EUA+for+sotrovimab+for+treatment+of+COVID-19 (accessed July 13, 2021)", "ArticleIdList": ["34181630"]}, {"Citation": "Drodal S, Rosik J, Lechowicz K, et al. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist. Update. 2021(January):100794. 10.1016/j.drup.2021.100794.", "ArticleIdList": ["PMC8654464", "34991982"]}, {"Citation": "Sebba A. Tocilizumab: the first interleukin-6-receptor inhibitor. Am J Health-Syst Pharm. 2008;65(15):1413\u20131418. doi: 10.2146/ajhp070449.", "ArticleIdList": ["10.2146/ajhp070449", "18653811"]}, {"Citation": "Stebbing J, Krishnan V, Bono SD, Ottaviani S, & Corbellino M (2020) Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol. Med. 12 (8). 10.15252/emmm.202012697", "ArticleIdList": ["PMC7300657", "32473600"]}, {"Citation": "Cov-lineages: VOC reports. https://cov-lineages.org/index.html#global_reports. (accessed December 9, 2021)"}, {"Citation": "Han P, Li L, Liu S, et al. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell. 2022;185(4):630\u2013640. doi: 10.1016/j.cell.2022.01.001.", "ArticleIdList": ["10.1016/j.cell.2022.01.001", "PMC8733278", "35093192"]}, {"Citation": "Kat A, Tn F, Az A, et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect. Dis. 2022;22(1):35\u201342. doi: 10.1016/S1473-3099(21)00475-8.", "ArticleIdList": ["10.1016/S1473-3099(21)00475-8", "PMC8397301", "34461056"]}, {"Citation": "Uriu K, Kimura I, Shirakawa K, et al. Neutralization of the SARS-CoV-2 mu variant by convalescent and vaccine serum. N Engl J Med. 2021;385(25):2397\u20132399. doi: 10.1056/NEJMC2114706.", "ArticleIdList": ["10.1056/NEJMC2114706", "PMC8609602", "34731554"]}, {"Citation": "Xie X, Han JB, Ma G, et al. Emerging SARS-CoV-2 B.1.621/mu variant is prominently resistant to inactivated vaccine-elicited antibodies. Zool Res. 2021;42(6):789\u2013791. doi: 10.24272/j.issn.2095-8137.2021.343.", "ArticleIdList": ["10.24272/j.issn.2095-8137.2021.343", "PMC8645883", "34704423"]}, {"Citation": "Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern, (n.d.). https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern (accessed December 9, 2021)."}, {"Citation": "Science brief: omicron (B.1.1.529) variant | CDC, (n.d.). https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-omicron-variant.html (accessed December 9, 2021)."}, {"Citation": "Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205\u20131211. doi: 10.1038/s41591-021-01377-8.", "ArticleIdList": ["10.1038/s41591-021-01377-8", "34002089"]}, {"Citation": "Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 omicron antigenic shift. Nature. 2021;602:664\u2013670. doi: 10.1038/s41586-021-04386-2.", "ArticleIdList": ["10.1038/s41586-021-04386-2", "PMC9531318", "35016195"]}, {"Citation": "Guo D, Duan H, Cheng Y, et al. Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies. Mol Biomed. 2022;3(1):1\u201318. doi: 10.1186/s43556-022-00074-3.", "ArticleIdList": ["10.1186/s43556-022-00074-3", "PMC9034971", "35461370"]}, {"Citation": "Du X, Tang H, Gao L, et al. Omicron adopts a different strategy from delta and other variants to adapt to host. Signal Transduct Target Ther. 2022;7(1):1\u20133. doi: 10.1038/s41392-022-00903-5.", "ArticleIdList": ["10.1038/s41392-022-00903-5", "PMC8830988", "35145066"]}, {"Citation": "Artese A, Svicher V, Costa G, et al (2020) Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resist. Update. 53. 10.1016/j.drup.2020.100721.", "ArticleIdList": ["PMC7448791", "33132205"]}, {"Citation": "Twomey JD, Luo S, Dean AQ, et al. COVID-19 update: the race to therapeutic development. Drug Resist Update. 2020;53:100733. doi: 10.1016/j.drup.2020.100733.", "ArticleIdList": ["10.1016/j.drup.2020.100733", "PMC7584885", "33161277"]}, {"Citation": "Andrew W, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;W1:W296\u2013W303. doi: 10.1093/nar/gky427.", "ArticleIdList": ["10.1093/nar/gky427", "PMC6030848", "29788355"]}, {"Citation": "Xiao T, Lu J, Zhang J, et al. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro. Nat Struct Mol Biol. 2021;28:202\u2013209. doi: 10.1101/2020.09.18.301952.", "ArticleIdList": ["10.1101/2020.09.18.301952", "PMC7895301", "33432247"]}, {"Citation": "Yuan S, Chan H, Hu Z. Using PyMOL as a platform for computational drug design. Wiley Interdiscip Rev Comput Mol Sci. 2017;7(2):e1298. doi: 10.1002/wcms.1298.", "ArticleIdList": ["10.1002/wcms.1298"]}, {"Citation": "G. C P, van, Zundert J, P. G. L. M, et al (2016) The HADDOCK2.4 web server: user-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 2016; 428:720\u2013725. 10.1016/j.jmb.2015.09.014.", "ArticleIdList": ["26410586"]}, {"Citation": "Fraser BJ, Beldar S, Seitova A, et al. Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activation. BioRxiv. 2021;1:1\u201319. doi: 10.1101/2021.06.23.449282.", "ArticleIdList": ["10.1101/2021.06.23.449282", "35676539"]}, {"Citation": "Barnes CO, Jette CA, Abernathy ME, et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature. 2020;183(4):1024\u20131042. doi: 10.1038/s41586-020-2852-1.", "ArticleIdList": ["10.1038/s41586-020-2852-1", "PMC8092461", "33045718"]}, {"Citation": "Wang J, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field. J Comput Chem. 2004;25(9):1157\u20131174. doi: 10.1002/jcc.20035.", "ArticleIdList": ["10.1002/jcc.20035", "15116359"]}, {"Citation": "Case, DA, Cerutti DS, Cheatham TE, Darden TA, & Kollman PA. Amber 2017, University of California, San Francisco. 10.13140/RG.2.2.36172.41606."}, {"Citation": "Jorgensen WL, Chandrasekhar J, Madura JD. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):926\u2013935. doi: 10.1063/1.445869.", "ArticleIdList": ["10.1063/1.445869"]}, {"Citation": "Miyamoto S, Kollman PA. Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem. 1992;13(8):952\u2013962. doi: 10.1002/jcc.540130805.", "ArticleIdList": ["10.1002/jcc.540130805"]}, {"Citation": "Humphrey Dalke A, Schulten K. VMD-visual molecular dynamics. J Mol Graph. 1996;14(1):33\u201338. doi: 10.1016/0263-7855(96)00018-5.", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Kottalam J, Case DA. Langevin modes of macromolecules: applications to crambin and DNA hexamers. Biopolymers. 1990;29:1409\u20131421. doi: 10.1002/bip.360291008.", "ArticleIdList": ["10.1002/bip.360291008", "2361153"]}, {"Citation": "Kollman PA, Massova I, Reyes C, et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Accounts Chem Res. 2000;33(12):889\u2013897. doi: 10.1021/ar000033j.", "ArticleIdList": ["10.1021/ar000033j", "11123888"]}, {"Citation": "Simonson T. Macromolecular electrostatics: continuum models and their growing pains. Curr Opin Struct Biol. 2001;11(2):243\u2013252. doi: 10.1016/S0959-440X(00)00197-4.", "ArticleIdList": ["10.1016/S0959-440X(00)00197-4", "11297935"]}, {"Citation": "Chen J, Liu X, Zhang S, et al. Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses. Phys Chem Chem Phys. 2019;22(4):2262\u20132275. doi: 10.1039/C9CP05704H.", "ArticleIdList": ["10.1039/C9CP05704H", "31917380"]}, {"Citation": "Letunic I, Bork P. Interactive tree of life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics. 2007;23(1):127\u2013128. doi: 10.1093/bioinformatics/btl529.", "ArticleIdList": ["10.1093/bioinformatics/btl529", "17050570"]}, {"Citation": "Ciccarelli FD, Doerks T, von Mering C, et al. Toward automatic reconstruction of a highly resolved tree of life. Sci. 2006;311(5765):1283\u20131287. doi: 10.1126/science.1123061.", "ArticleIdList": ["10.1126/science.1123061", "16513982"]}, {"Citation": "David T, David L, et al. Characterization of protein-protein interaction interfaces from a single species. Plos One. 2011;6:e21053. doi: 10.1371/journal.pone.0021053.", "ArticleIdList": ["10.1371/journal.pone.0021053", "PMC3124478", "21738603"]}, {"Citation": "Peri C, Morra G, Colombo G. Surface energetics and protein-protein interactions: analysis and mechanistic implications. Sci Rep. 2016;6(1):24035. doi: 10.1038/srep24035.", "ArticleIdList": ["10.1038/srep24035", "PMC4822145", "27050828"]}, {"Citation": "Eisenhaber F, Lijnzaad P, Argos P, et al. The double cubic lattice method: efficient approaches to numerical integration of surface area and volume and to dot surface contouring of molecular assemblies. J Comput Chem. 1995;16(3):273\u2013284. doi: 10.1002/jcc.540160303.", "ArticleIdList": ["10.1002/jcc.540160303"]}, {"Citation": "Stecula A, Schlessinger A, Giacomini KM, et al. Human concentrative nucleoside transporter 3 (hCNT3, SLC28A3) forms a cyclic homotrimer. Biochem. 2017;56(27):3475. doi: 10.1021/acs.biochem.7b00339.", "ArticleIdList": ["10.1021/acs.biochem.7b00339", "PMC6917504", "28661652"]}, {"Citation": "Hussain M, Jabeen N, Amanullah A, et al. Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions. AIMS Microbiol. 2020;6(3):350\u2013360. doi: 10.3934/microbiol.2020021.", "ArticleIdList": ["10.3934/microbiol.2020021", "PMC7535071", "33029570"]}, {"Citation": "Cerutti G, Guo Y, Zhou T, et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe. 2021;29(5):819\u2013833. doi: 10.1101/2021.01.10.426120.", "ArticleIdList": ["10.1101/2021.01.10.426120", "PMC7953435", "33789084"]}, {"Citation": "Cai Y, Zhang J, Xiao T, Peng H, Chen B. Distinct conformational states of SARS-CoV-2 spike protein. Sci. 2020;369(6511):1586\u20131592. doi: 10.1126/science.abd4251.", "ArticleIdList": ["10.1126/science.abd4251", "PMC7464562", "32694201"]}, {"Citation": "Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221\u2013224. doi: 10.1038/s41586-020-2179-y.", "ArticleIdList": ["10.1038/s41586-020-2179-y", "PMC7328981", "32225175"]}, {"Citation": "Yu W, Wu X, Ren J, et al. Mechanistic insights to the binding of antibody CR3022 against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: a computational study. Comb Chem High Throughput Screen. 2020;24(7):1069\u20131082. doi: 10.2174/1386207323666201026160500.", "ArticleIdList": ["10.2174/1386207323666201026160500", "33106140"]}, {"Citation": "Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ Res. 2000;87(5):E1\u20139. doi: 10.2174/1386207323666201026160500.", "ArticleIdList": ["10.2174/1386207323666201026160500", "10969042"]}, {"Citation": "Crackower M, Sarao R, Oudit G, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822\u2013828. doi: 10.1038/nature00786.", "ArticleIdList": ["10.1038/nature00786", "12075344"]}, {"Citation": "Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215\u2013220. doi: 10.1038/s41586-020-2180-5.", "ArticleIdList": ["10.1038/s41586-020-2180-5", "32225176"]}, {"Citation": "Shang J, Wan Y, Liu C, et al. Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Pathog. 2020;16(3):e1008392. doi: 10.1371/journal.ppat.1008392.", "ArticleIdList": ["10.1371/journal.ppat.1008392", "PMC7082060", "32150576"]}, {"Citation": "Zhang J, Cai Y, Xiao T, et al. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Sci. 2021;372(6541):525\u2013530. doi: 10.1126/science.abf2303.", "ArticleIdList": ["10.1126/science.abf2303", "PMC8139424", "33727252"]}, {"Citation": "Jackson CB, Farzan M, Chen B, et al. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3\u201320. doi: 10.1073/pnas.2003138117.", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC8491763", "34611326"]}, {"Citation": "Zhao H, Lu L, Zheng P, et al. SARS-CoV-2 omicron variant shows less efficient replication and fusion activity when compared with delta variant in TMPRSS2-expressed cells. Emerg Microbes Infect. 2022;11:277\u2013283. doi: 10.1080/22221751.2021.2023329.", "ArticleIdList": ["10.1080/22221751.2021.2023329", "PMC8774049", "34951565"]}, {"Citation": "Jawad B, Adhikari P, Podgornik R, Ching WY. Key interacting residues between RBD of SARS-CoV-2 and ACE2 receptor: combination of molecular dynamics simulation and density functional calculation. J Chem Inf Model. 2021;61(9):4425\u20134441. doi: 10.1021/acs.jcim.1c00560.", "ArticleIdList": ["10.1021/acs.jcim.1c00560", "34428371"]}, {"Citation": "Csl A, Yy A, Hong CB, et al. Mutations on RBD of SARS-CoV-2 omicron variant result in stronger binding to human ACE2 receptor. Biochem Biophys Res Commun. 2021;590:34\u201341. doi: 10.1016/j.bbrc.2021.12.079.", "ArticleIdList": ["10.1016/j.bbrc.2021.12.079", "PMC8702632", "34968782"]}, {"Citation": "Starr TN, Greaney AJ, Hilton SK, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020;182(5):1295\u20131310. doi: 10.1016/j.cell.2020.08.012.", "ArticleIdList": ["10.1016/j.cell.2020.08.012", "PMC7418704", "32841599"]}, {"Citation": "Norel R, Sheinerman F, Petrey D, Honig B. Electrostatic contributions to protein-protein interactions: fast energetic filters for docking and their physical basis. Protein Sci. 2008;10(11):2147\u20132161. doi: 10.1110/ps.12901.", "ArticleIdList": ["10.1110/ps.12901", "PMC2374075", "11604522"]}, {"Citation": "Ali F, Kasry A, Amin M. The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutation. ArXiv. 2021;10:100086. doi: 10.1016/j.medidd.2021.100086.", "ArticleIdList": ["10.1016/j.medidd.2021.100086", "PMC7923861", "33681755"]}, {"Citation": "Evans J P, Liu S L (2021) Role of host factors in SARS-CoV-2 entry. J Biol Chem. 297(1). 10.1016/j.jbc.2021.100847.", "ArticleIdList": ["PMC8160279", "34058196"]}, {"Citation": "Hussain M, Jabeen N, Amanullah A, et al (2021) Structural basis of SARS-CoV-2 spike protein priming by TMPRSS2. BioRxiv.10.1101/2020.04.21.052639."}, {"Citation": "Shah B, Modi P, Sagar SR. In silico studies on therapeutic agents for COVID-19: drug repurposing approach. Life Sci. 2020;252:e117652. doi: 10.1016/j.lfs.2020.117652.", "ArticleIdList": ["10.1016/j.lfs.2020.117652", "PMC7194845", "32278693"]}, {"Citation": "Cardinale D, Guaitoli G, Tondi D, et al. Protein\u2013protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase. Proc Natl Acad Sci U S A. 2011;108(34):E542\u2013E549. doi: 10.1073/pnas.1104829108.", "ArticleIdList": ["10.1073/pnas.1104829108", "PMC3161595", "21795601"]}, {"Citation": "Papa G, Mallery DL, Albecka A, Welch LG, James LC. Furin cleavage of SARS-CoV-2 spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathog. 2021;17:e1009246. doi: 10.1371/journal.ppat.1009246.", "ArticleIdList": ["10.1371/journal.ppat.1009246", "PMC7861537", "33493182"]}, {"Citation": "Ou T, Mou H, Zhang L, et al. Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. PLoS Pathog. 2021;17:e1009212. doi: 10.1371/journal.ppat.1009212.", "ArticleIdList": ["10.1371/journal.ppat.1009212", "PMC7845965", "33465165"]}, {"Citation": "Saito A, Irie T, Suzuki R, et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 delta P681R mutation. Nature. 2021;602:300\u2013306. doi: 10.1038/s41586-021-04266-9.", "ArticleIdList": ["10.1038/s41586-021-04266-9", "PMC8828475", "34823256"]}, {"Citation": "Peacock TP, Goldhill DH, Zhou J, et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat Microbiol. 2021;6:899\u2013909. doi: 10.1038/s41564-021-00908-w.", "ArticleIdList": ["10.1038/s41564-021-00908-w", "33907312"]}, {"Citation": "Paoloni-Giacobino A, Chen H, Peitsch MC, et al. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22. 3. Genomics. 1997;44:309\u2013320. doi: 10.1006/geno.1997.4845.", "ArticleIdList": ["10.1006/geno.1997.4845", "9325052"]}, {"Citation": "Koch J, Uckeley Z, Doldan P, et al (2021) TMPRSS2 expression dictates the entry route used by SARS-CoV-2 infect host cells. EMBO J. 40(16). 10.15252/embj.2021107821.", "ArticleIdList": ["PMC8365257", "34159616"]}, {"Citation": "Gupta R (2022) SARS-CoV-2 omicron spike mediated immune escape and tropism shift. Res Sq. 10.21203/rs.3.rs-1191837/v."}, {"Citation": "Meng B, Abdullahi A, Ferreira IATM, et al. Altered TMPRSS2 usage by SARS-CoV-2 omicron impacts infectivity and fusogenicity. Nature. 2022;603:706\u2013714. doi: 10.1038/s41586-022-04474-x.", "ArticleIdList": ["10.1038/s41586-022-04474-x", "PMC8942856", "35104837"]}, {"Citation": "Shuai H, Chan FW, Hu B, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 omicron. Nature. 2022;603:693\u2013699. doi: 10.1038/s41586-022-04442-5.", "ArticleIdList": ["10.1038/s41586-022-04442-5", "35062016"]}, {"Citation": "Robbiani DF, Gaebler C, Muecksch F, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584:437\u2013442. doi: 10.1038/s41586-020-2456-9.", "ArticleIdList": ["10.1038/s41586-020-2456-9", "PMC7442695", "32555388"]}, {"Citation": "Isabella F, Steven K, Rawlings D, et al. SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion. J Infect Dis. 2021;224(6):989\u2013994. doi: 10.1093/infdis/jiab368.", "ArticleIdList": ["10.1093/infdis/jiab368", "PMC8420622", "34260717"]}, {"Citation": "Wang R, Zhang Q, Ge J, et al. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity. 2021;54(7):1611\u20131621. doi: 10.1016/j.immuni.2021.06.003.", "ArticleIdList": ["10.1016/j.immuni.2021.06.003", "PMC8185182", "34166623"]}, {"Citation": "Baral P, Bhattarai N, Hossen L, et al. Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 delta variant B.1.617.2 and implications for immune evasion. Biochem Biophys Res Commun. 2021;574:14\u201319. doi: 10.1016/j.bbrc.2021.08.036.", "ArticleIdList": ["10.1016/j.bbrc.2021.08.036", "PMC8364676", "34425281"]}, {"Citation": "Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021;593(7857):130\u2013135. doi: 10.1038/s41586-021-03398-2.", "ArticleIdList": ["10.1038/s41586-021-03398-2", "33684923"]}, {"Citation": "Ortega JT, Serrano ML, Pujol FH, et al. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis. EXCLI J. 2020;19:410\u2013417. doi: 10.17179/excli2020-1167.", "ArticleIdList": ["10.17179/excli2020-1167", "PMC7081066", "32210742"]}, {"Citation": "Jafary F, Jafari S, Ganjalikhany MR. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2. Sci Rep. 2021;11(1):6927. doi: 10.1038/s41598-021-86380-2.", "ArticleIdList": ["10.1038/s41598-021-86380-2", "PMC7994905", "33767306"]}, {"Citation": "Sigal A, Milo R, Jassat W. Estimating disease severity of omicron and delta SARS-CoV-2 infections. Nat Rev Immunol. 2022;22(4):267\u2013269. doi: 10.1038/s41577-022-00720-5.", "ArticleIdList": ["10.1038/s41577-022-00720-5", "PMC9002222", "35414124"]}, {"Citation": "Cong Z, Evans JP, Qu P, et al (2021) Neutralization and stability of SARS-CoV-2 omicron variant. bioRxiv. Preprint at 10.1101/2021.2012.2016.472934."}, {"Citation": "Braga L, Ali H, Secco I, et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature. 2021;594:88\u201393. doi: 10.1038/s41586-021-03491-6.", "ArticleIdList": ["10.1038/s41586-021-03491-6", "PMC7611055", "33827113"]}, {"Citation": "Edara VV, Manning KE, Ellis M, et al (2022) mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant. Cell Rep. Med. 3(2). 10.1016/j.xcrm.2022.100529.", "ArticleIdList": ["PMC8784612", "35233550"]}, {"Citation": "Starr TN, Greaney AJ, Addetia A, et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Sci. 2021;371:850\u2013854. doi: 10.1126/science.abf9302.", "ArticleIdList": ["10.1126/science.abf9302", "PMC7963219", "33495308"]}, {"Citation": "Mccallum M, Czudnochowski N, Rosen LE, et al. Structural basis of SARS-CoV-2 omicron immune evasion and receptor engagement. Sci. 2021;375(6583):864\u2013868. doi: 10.1126/science.abn8897.", "ArticleIdList": ["10.1126/science.abn8897", "PMC9427005", "35076256"]}, {"Citation": "Liu L, Iketani S, Guo Y, et al. Striking antibody evasion manifested by the omicron variant of SARS-CoV-2. Nature. 2021;602(7898):676\u2013681. doi: 10.1038/s41586-021-04388-0.", "ArticleIdList": ["10.1038/s41586-021-04388-0", "35016198"]}, {"Citation": "Planas D, Saunders N, Maes P, et al. Considerable escape of SARS-CoV-2 variant omicron to antibody neutralization. Nature. 2021;596:276\u2013280. doi: 10.1038/s41586-021-04389-z.", "ArticleIdList": ["10.1038/s41586-021-04389-z", "35016199"]}, {"Citation": "Hu J, Peng P, Cao X, et al. Increased immune escape of the new SARS-CoV-2 variant of concern omicron. Cell Mol Immunol. 2022;19:293\u2013295. doi: 10.1038/s41423-021-00836-z.", "ArticleIdList": ["10.1038/s41423-021-00836-z", "PMC8749347", "35017716"]}, {"Citation": "Shi J, Jing Z, Li S, et al. Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases. PLoS ONE. 2015;10(12):e0144475. doi: 10.1371/journal.pone.0144475.", "ArticleIdList": ["10.1371/journal.pone.0144475", "PMC4671582", "26641892"]}, {"Citation": "Abdi SAH, Ali A, Sayed SF, et al. Multi-epitope-based vaccine candidate for monkeypox: an in silico approach. Vaccines. 2022;10:1564. doi: 10.3390/vaccines10091564.", "ArticleIdList": ["10.3390/vaccines10091564", "PMC9504424", "36146643"]}, {"Citation": "Joshi A, Ray NM, Singh J, et al. T-cell epitope-based vaccine designing against orthohantavirus: a causative agent of deadly cardio-pulmonary disease. Netw Model Anal Health Inform Bioinforma. 2022;11(1):1\u201310. doi: 10.1007/s13721-021-00339-x.", "ArticleIdList": ["10.1007/s13721-021-00339-x", "PMC8649322", "34900515"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "10"}, {"Year": "2023", "Month": "3", "Day": "10"}, {"Year": "2023", "Month": "3", "Day": "28", "Hour": "19", "Minute": "6"}, {"Year": "2023", "Month": "3", "Day": "25", "Hour": "0", "Minute": "20"}, {"Year": "2023", "Month": "3", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["36964244", "PMC10038388", "10.1007/s00894-023-05509-4", "10.1007/s00894-023-05509-4"]}}], "PubmedBookArticle": []}